back to Australia directory
australia clinical guidance

Shingles (herpes zoster)

A detailed Australian summary of shingles (herpes zoster), with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Recognise unilateral dermatomal pain and vesicles and examine for eye, ear, motor, disseminated or immunocompromised involvement. Start antiviral treatment within the Australian indication window for eligible people, using kidney-adjusted dosing from current product information. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:Australian Immunisation Handbook

The Bottom Line

  • Recognise unilateral dermatomal pain and vesicles and examine for eye, ear, motor, disseminated or immunocompromised involvement.
  • Start antiviral treatment within the Australian indication window for eligible people, using kidney-adjusted dosing from current product information.
  • Hutchinson-sign nasal lesions increase ocular involvement risk but their absence does not safely exclude eye disease.
  • Cover lesions, use hand hygiene and avoid susceptible pregnant or immunocompromised contacts until lesions crust, following local infection-control advice.
sources for this section:Australian Immunisation Handbook

Practical clinical workflow

1

Topic-specific assessment action

Recognise unilateral dermatomal pain and vesicles and examine for eye, ear, motor, disseminated or immunocompromised involvement.
2

Topic-specific diagnostic action

Cover lesions, use hand hygiene and avoid susceptible pregnant or immunocompromised contacts until lesions crust, following local infection-control advice.
3

Topic-specific management action

Treat acute pain actively and review persistent neuropathic pain, while offering vaccination later under the Australian Immunisation Handbook schedule.
4

Topic-specific follow-through

Postherpetic neuralgia risk rises with age and severe acute pain; review early for neuropathic treatment rather than extending antiviral courses.
sources for this section:Australian Immunisation Handbook

Safety boundaries and escalation

  • Eye pain or rash on the ophthalmic division, facial weakness, ear vesicles, meningism, dissemination or severe immunocompromise requires urgent specialist assessment.
  • Live and recombinant zoster vaccines have different immune-status rules; follow the current Australian Immunisation Handbook.
sources for this section:Australian Immunisation Handbook

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:Australian Immunisation Handbook

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Australian Immunisation Handbook

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Australian Government Department of Health, Disability and AgeingAustralian Immunisation HandbookLiving web handbook checked 2026-08-20 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.